Platelet activation in diabetic cardiovascular autonomic neuropathy

Diabetic Medicine

Volumn 16, Issue 10, 1999, Pages 848-852

  Rauch, Ursula ^b   Ziegler, D ^a   Piolot, R ^a   Schwippert, B ^a   Benthake, H ^a   Schultheiss, H P ^c   Tschoepe, D ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Diabetic cardiovascular autonomic neuropathy; Flow cytometry; Platelet activation

Indexed keywords

CD63 ANTIGEN; FIBRINOGEN RECEPTOR; PADGEM PROTEIN; THROMBOSPONDIN;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; BINDING SITE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; FEMALE; HEART INNERVATION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PROTEIN DETERMINATION; THROMBOCYTE ACTIVATION;

ADULT; ANTIGENS, CD; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; FEMALE; FLOW CYTOMETRY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET MEMBRANE GLYCOPROTEINS; THROMBOSPONDINS;

EID: 0343391281     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00160.x     Document Type: Article

References (30)

1. 1 Takase B, Kurita A, Noritake M, Uehata A, Maruyama T, Nagayoshi H et al. Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure. J Electrocardiol 1992; 25: 78-88.
2. 2 Ewing DJ, Boland O, Neilson JM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 1991; 34: 182-185.
3. 3 Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis, and treatment. Diabetes Metab Rev 1994; 10; 339-383.
4. 4 Lombardi F, Sandrone G, Pernpruner S, Sala R, Garimoldi M, Cerutti S et al. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction. Am J Cardiol 1987; 60: 1239-1245.
5. 5 Moser M, Lehofer M, Sedminek A et al. Heart rate variability as a prognostic tool in cardiology. A contribution to the problem from a theoretical point of view. Circulation 1994; 90: 1078-1082.
6. 6 Casolo GC, Stroder P, Signorini C et al. Heart rate variability during the acute phase of myocardial infarction. Circulation 1992; 85: 2073-2079.
7. 7 Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991; 18: 464-472.
8. 8 Kleiger RE, Miller JP, Bigger JT, Lux M, Zapotoczky HG, Kenner T. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 57: 256-262.
9. 9 Brown FM, Brink SJ, Freeman R, Rabinowe SL. Anti-sympathitic nervous system antibodies. Diminished catecholamines with orthostasis. Diabetes 1989; 38: 938-941.
10. 10 Gilbey SG, Hussain Mj Watkins PJ, Vergani D. Cell-mediated immunity and symptomatic diabetic autonomic neuropathy. Diabetic Med 1988; 5: 845-848.
11. 11 Timperley WR. Vascular and coagulation abnormalities in diabetic neuropathy and encephalopathy. In Gries FA, Freund FJ, Rabe F, Berger H eds. Aspects of Autonomic Neuropathy in Diabetes. International Symposium of the German Diabetes Association, Düsseldorf, May 1978 Suppl. 9). Stuttgard and New York: Georg Thieme-Verlag , 1980; 43-49.
12. 12 Trip MD, Cats VM, Van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Eng J Med 1990; 322: 1549-1554.
13. 13 Tschoepe D, Schultheiss HP, Kolarov P, Schwippert B, Dannehl K, Nieuwenhuis HK et al. Platelet Membrane Activation Markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993; 88: 37-42.
14. 14 Rauch U, Chesebro J, Fuster V, Badimon JJ. Unstable angina and the role of thrombus. Acute Coronary Synd 1997; 1: 2-8.
15. 15 Flores NA, Goulielmos NV, Seghatchian MJ, Sheridan DJ. Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrthythmogemic effects. Cardiovasc Res 1994; 28: 1662-1671.
16. 16 Gebalska J, Herbaczynska-Cedro K, Ceremuzynski L. Platelet adhesion is related to heart rhythm disturbances in the acute phase of myocardial infarction. Int J Cardiol 1993; 38: 19-24.
17. 17 Tschoepe D, Rauch U, Schwippert B. Platelet-leukocyte cross-talk in diabetes mellitus. Horm Metab Res 1997; 29: 631-635.
18. 18 Kahn R. Proceedings of a Consensus Development Conference on Standardized Measures in Diabetic Neuropathy. Autonomic nervous system testing. Diabetes Care 1992; 15: 1095-1103.
19. 19 Ziegler D, Dannehl K, Muchlen H, Spueler M, Gries FA. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabetic Med 1992; 9: 806-814.
20. 20 Ziegler D, Laux G, Dannehl K, Spuler M, Muhlen H, Mayor P et al. Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabetic Med 1992; 9: 166-175.
21. 21 Johnston GI, Cook RG, McEver RP. Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 1989; 56: 1033-1044.
22. 22 Legrand C, Dubernard V, Kieffer N, Nurden A. Use of a monoclonal antibody to measure the surface expression of thrombospondin following platelet activation. Eur J Biochem 1988; 171: 393-399.
23. 23 Nieuwenhuis HK, van Oosterhout JJ, Rozemuller E, van Iwaarden F, Sixma JJ. Studies with monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987; 70: 838-845.
24. 24 Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brien JR, Yarnell JWG. Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 1991; 83: 38-44.
25. 25 Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-1411.
26. 26 Schultheiss HP, Tschoepe D, Esser J, Schwippert B, Roesen P, Nieuwenhuis HK et al. Large platelet continue to circulate in an activated state after myocardial infarction. Eur J Clin Invest 1994; 24: 243-247.
27. 27 Hærem JW. Platelets aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery disease. Atherosclerosis 1972; 15: 199-213.
28. 28 Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes 1995; 44: 890-894.
29. 29 Sung CP, Arleth AJ, Heuerstein GZ. Neuropeptide Y upregulates the adhesiveness of human endothelial cells for leukocytes. Circ Res 1991; 68: 314-318.
30. 30 Sladky JT, Tschoepe RL, Greenberg JH, Brown MJ. Peripheral neuropathy after chronic endoneurial ischemia. Ann Neurol 1991; 29: 272-278.